Spread the love In an era of rapid technological advancement, social upheaval, and environmental challenges, certain ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

The scientist who was jailed for three years for performing illegal gene-altering on babies has criticized ethics for slowing ...

A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

With spring break quickly approaching, let’s take a look at some breaking scientific discoveries and news, from a new sickle ...

A new essay brings us into a space of looking at what the top human minds have accomplished over the centuries, and why.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Every year, we hold a STAT Madness tournament to find the best ...

Vertex's success since the early 2010s is due to its work in CF. The company famously markets the only approved medicines that target the underlying causes of this condition. Thanks to its monopoly, ...

Vaclav Smil’s 'How to Feed the World' explores food waste, rising costs, and solutions to global food insecurity, with praise ...